Work

Precision Therapy in RAS Mutant Colorectal Cancer

Year: 2020

Type: article

Source: Gastroenterology

DOI: 10.1053/j.gastro.2019.12.051

Authors: Rodrigo Dienstmann, Kate Connor, Annette T. Byrne, W.H. Fridman, D. Lambrechts, A. Sadanandam, L. Trusolino, J.H.M. Prehn, J. Tabernero, W. Kolch

Institutions: Vall d'Hebron Institute of Oncology, Royal College of Surgeons in Ireland

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Health Research Board, Royal College of Surgeons in Ireland, European Commission, Science Foundation Ireland, University College Dublin, Université Paris Descartes, Université Pierre et Marie Curie, Fundació Institut de Recerca Hospital Universitari Vall d’Hebron, Horizon 2020

Awards: G2027470865, Development of personalised medicine approaches for the clinical application of IAP antagonists in metastatic and high risk early stage colorectal cancer, G2274722937, G3126405203, Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions, G434337789, Overcoming Drug Resistance in Metastatic Malignant Melanoma by Personalizing Treatment, ColoForetell: A Xenopatient Discovery Platform for the integrated Systems based Identification of Predictive Biomarkers for Targeted Therapies in Metastatic Colorectal Cancer

OpenAlex ID: W2999396499

FWCI: 3.071

Cites: 27

Cited by: 76

Related to: 10